Delivery Order SPE2DB22D1017-SPE2DB24FF5ZJ
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company, for the provision of Contrave ER 8-90 mg tablets. The Delivery Order, valued at $6,752.60, was awarded on a Firm Fixed Price basis without any set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025. This single-award...
- This federal contract award is for the delivery of Contrave ER 8-90 mg tablets (120 tablets per bottle) to the Defense Logistics Agency (DLA). The $3,770.10 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, without any set-aside designation. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to...
- This federal contract award was issued by the Medical Supply Chain, a defense agency, to the Corporate Office division of Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,250.24 firm fixed price delivery order is for the provision of Contrave ER 8-90 mg tablets, a prescription medication. The award has a period of performance ending on July 9, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $30,209.50 delivery order is for the supply of CONTRAVE ER 8-90 MG TABLET 120S, a pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) between the DLA and Amerisourcebergen, valued at up to $999,999,999.00, which serves as the primary vehicle for the company...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Contrave ER 8-90 mg tablets. The firm-fixed-price, $2,970.63 delivery order contract has an ultimate completion date of December 5, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
- This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of the drug Contrave ER 8-90 mg tablets. The delivery order, valued at $5,367.46, is a firm-fixed-price contract with an ultimate completion date of October 24, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The award, a firm fixed price delivery order, is for the supply of Contrave ER 8-90 mg tablets in 120-count bottles, with a ceiling value of $6,956.26 and a performance period through March 26, 2024. The contract is not set-aside and is part of a larger...
- This federal contract award, valued at $3,855.89, was granted to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA), a defense agency. The contract is for the delivery of the pharmaceutical product CONTRAVE ER 8-90 MG TABLET 120S. This is a firm fixed price delivery order contract with a completion date of July 16, 2024. Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, holds a large...
- This federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, provides for the delivery of the pharmaceutical product CONTRAVE ER 8-90 MG TABLET 120S to the U.S. government. The $8,784.34 firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DoD). Amerisourcebergen holds a single-award Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $2,725.60 firm fixed price delivery order is for 120 tablets of Contrave ER 8-90 mg, a medication used to treat obesity. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. Under this single-award IDC, Amerisourcebergen...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB24FF5ZJDelivery Order
This federal contract award, valued at $19,760.77, was issued by the Defense Logistics Agency (DLA) to the Corporate Office division of Amerisourcebergen Drug Corporation, a major pharmaceutical distributor and supplier to the U.S. government. The award is for the delivery of Contrave ER 8-90 mg tablets, a treatment for chronic conditions. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a wide range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The current award is a specific delivery order under this larger IDC. The contract does not have a set-aside designation, indicating it was awarded through full and open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $19.8k | 4/15/24 |